AI
LHDX

Atom Investors’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Atom Investors’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-85,921
Closed -$307K – 331
2022
Q1 		$307K Buy
85,921
+30,442
+55% +$150K 0.14% 137
2021
Q4 		$478K Buy
+55,479
New +$353K 0.08% 167

Other funds holding LHDX

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
EV
Eclipse Ventures Palo Alto, California $2.57B AUM
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return
CWA
Choice Wealth Advisors Waterville, Maine $285M AUM 19.08% 1-Year Est. Return
CWA
Consilio Wealth Advisors Bellevue, Washington $417M AUM 20.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Atom Investors's LHDX Position: Q2 2022 in Review

Atom Investors sold out of Lucira Health, Inc. Common Stock (LHDX) in Q2 2022, closing a stake of 85,921 shares — an estimated $307K sold.

Atom Investors first reported a position in LHDX in Q4 2021 and held it in 2 quarters. The position peaked at $478K in Q4 2021. 38 funds tracked by Wall St. Rank hold LHDX as of Q2 2022.

  • Atom Investors reported no remaining Lucira Health, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Atom Investors sold 85,921 Lucira Health, Inc. Common Stock shares in Q2 2022, an estimated $307K.
  • Atom Investors first reported a position in Lucira Health, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Atom Investors's Lucira Health, Inc. Common Stock position peaked at $478K in Q4 2021.
  • 38 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q2 2022.

Based on Atom Investors's 13F filing for Q2 2022, filed 15 Aug 2022.